Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01650259
Recruitment Status : Completed
First Posted : July 26, 2012
Last Update Posted : November 7, 2017
Eli Lilly and Company
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 5, 2017
  Actual Study Completion Date : September 5, 2017